Filing Details
- Accession Number:
- 0001225208-11-009727
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-15 18:56:16
- Reporting Period:
- 2011-03-11
- Filing Date:
- 2011-03-15
- Accepted Time:
- 2011-03-15 18:56:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1183765 | Threshold Pharmaceuticals Inc | THLD | Pharmaceutical Preparations (2834) | 943409596 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1199037 | C James Gaither | 755 Page Mill Road, Suite A-200 Palo Alto CA 94304-1005 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-03-11 | 5,278 | $2.10 | 11,893 | No | 4 | P | Indirect | By Ltd Partnership |
| Common Stock | Acquisiton | 2011-03-11 | 5,278 | $2.10 | 29,079 | No | 4 | P | Indirect | By Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Ltd Partnership |
| No | 4 | P | Indirect | By Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock Warrant | Acquisiton | 2011-03-11 | 2,111 | $2.10 | 2,111 | $2.46 |
| Common Stock | Common Stock Warrant | Acquisiton | 2011-03-11 | 2,111 | $2.10 | 2,111 | $2.46 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,111 | 2011-03-16 | 2016-03-16 | No | 4 | P | Indirect |
| 2,111 | 2011-03-16 | 2016-03-16 | No | 4 | P | Indirect |
Footnotes
- Acquired from Issuer pursuant to Underwriting Agreement dated March 11, 2011.
- Purchase price per unit. Each unit consists of 1 common share and a warrant to purchase 0.4 of a share of common stock at an exercise price of $2.46 per share.
- Shares held by a limited partnership of which the reporting person is the trustee of a trust which is the General Partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
- Shares held by a trust of which the reporting person is the trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Billionaire Hedge Funds
